Tenet Healthcare (NYSE:THC) Stock Rating Upgraded by Wall Street Zen

Tenet Healthcare (NYSE:THC) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued on Monday.

Several other equities research analysts have also issued reports on THC. Stephens reissued an “overweight” rating and issued a $285.00 target price on shares of Tenet Healthcare in a report on Monday, July 27th. Barclays boosted their price target on Tenet Healthcare from $240.00 to $271.00 and gave the stock an “overweight” rating in a report on Friday, July 24th. Morgan Stanley increased their price objective on shares of Tenet Healthcare from $254.00 to $274.00 and gave the company an “overweight” rating in a report on Monday, July 27th. Wells Fargo & Company upped their target price on shares of Tenet Healthcare from $213.00 to $231.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Finally, TD Cowen raised their target price on shares of Tenet Healthcare from $233.00 to $263.00 and gave the company a “buy” rating in a research note on Monday, July 27th. Seventeen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $271.00.

Tenet Healthcare Stock Performance

Shares of THC opened at $253.81 on Monday. The business has a fifty day moving average of $195.15 and a 200 day moving average of $200.11. The firm has a market capitalization of $21.86 billion, a P/E ratio of 9.79, a PEG ratio of 0.95 and a beta of 1.23. Tenet Healthcare has a one year low of $157.58 and a one year high of $262.68. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The company had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. During the same quarter last year, the firm posted $4.02 earnings per share. The firm’s revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, sell-side analysts anticipate that Tenet Healthcare will post 21.09 EPS for the current year.

Insider Buying and Selling

In related news, Director Christopher S. Lynch sold 3,837 shares of the company’s stock in a transaction dated Monday, July 27th. The shares were sold at an average price of $243.44, for a total transaction of $934,079.28. Following the transaction, the director directly owned 9,568 shares in the company, valued at approximately $2,329,233.92. This represents a 28.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the sale, the director directly owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. The trade was a 10.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 33,353 shares of company stock valued at $7,683,517 over the last 90 days. 0.97% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Tenet Healthcare

A number of large investors have recently bought and sold shares of THC. Swedbank AB lifted its holdings in Tenet Healthcare by 14.7% during the 4th quarter. Swedbank AB now owns 146,133 shares of the company’s stock valued at $29,040,000 after buying an additional 18,750 shares in the last quarter. Hsbc Holdings PLC increased its position in shares of Tenet Healthcare by 3,478.7% during the fourth quarter. Hsbc Holdings PLC now owns 266,400 shares of the company’s stock worth $53,269,000 after acquiring an additional 258,956 shares during the period. Jackson Creek Investment Advisors LLC raised its stake in shares of Tenet Healthcare by 235.6% during the fourth quarter. Jackson Creek Investment Advisors LLC now owns 9,032 shares of the company’s stock valued at $1,795,000 after acquiring an additional 6,341 shares in the last quarter. Louisiana State Employees Retirement System purchased a new stake in shares of Tenet Healthcare in the first quarter valued at approximately $4,812,000. Finally, Brandywine Global Investment Management LLC increased its holdings in Tenet Healthcare by 20.5% during the 4th quarter. Brandywine Global Investment Management LLC now owns 126,248 shares of the company’s stock worth $25,088,000 after purchasing an additional 21,435 shares during the period. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.